| Old Articles: <Older 50681-50690 Newer> |
|---|
 |
The Motley Fool
July 29, 2011
Tamara Rutter |
A Retail Stock Worthy of Your Portfolio Is Target a bargain for long-term investors?   |
The Motley Fool
July 29, 2011
John Maxfield |
3 Trends Dominating Earnings Season Despite a largely positive earnings season, experienced investors are focusing on three interesting trends. |
The Motley Fool
July 29, 2011
Shubh Datta |
A Drug Retailer for Your Portfolio With a strong balance sheet, Walgreen looks like a good buy. |
The Motley Fool
July 29, 2011
Andrew Tonner |
4 Stocks With Stellar Earnings Let's see how these movers and shakers fared this earnings season. |
The Motley Fool
July 29, 2011
Jim Mueller |
Solid, Steady Performance Is the Secret to This Company's Success Not a blowout quarter, but not a disappointment, either. When electricity inverter maker Power-One reported earnings last night, I was pretty excited. |
The Motley Fool
July 29, 2011
Sean Williams |
Goodyear Puts the Pedal to the Metal Record revenue is nothing to ignore as this turnaround story kicks into high gear. |
The Motley Fool
July 29, 2011
Bryan Hinmon |
Rising Star Buy: Aflac Investors are down on the duck, but it will fly again. |
The Motley Fool
July 29, 2011
Sean Williams |
Another Day, Another Loss For Cell Therapeutics Cell Therapeutics is giving shareholders that sinking feeling. |
The Motley Fool
July 29, 2011
Brian Orelli |
2 Biotechs, 1 Promising Cancer Drug Perifosine on the home stretch. |
The Motley Fool
July 29, 2011
Brian Orelli |
Merck's Making All the Right Long-Term Moves Job cuts, but they're not in research. |
| <Older 50681-50690 Newer> Return to current articles. |
